Join the club for FREE to access the whole archive and other member benefits.

Jesús Gil

Scientist at MRC London Institute of Medical Sciences that works on senolytics and cancer therapy

Jesús was born in Zaragoza, Spain. He obtained his PhD, on the elucidation of how the dsRNA-dependent protein kinase induces apoptosis and activates NF-kB, in 2000 at the Universidad Autónoma in Madrid.

From 2000 to 2003 he worked with David Beach at the Wolfson Institute for Biomedical Research, University College London, where he screened for genes bypassing senescence, identifying CBX7. In January 2004, he joined Gordon Peters' group at the CRUK London Research Institute, investigating how CBX7 regulates the INK4/ARF locus.

During 2005 he worked in Scott Lowe's laboratory at Cold Spring Harbor, New York, developing models to study CBX7 function in vivo. Since Nov. 2005 he leads the Cell Proliferation Group at the MRC Clinical Sciences Centre, investigating the genetic and epigenetic regulation of the INK4a/ARF locus by PcG complexes and screening for agents controlling senescence. In November 2008, Jesús was named an EMBO Young Investigator.

Visit website: https://www.imperial.ac.uk/people/jesus.gil

See also: Academia Imperial College London (ICL) - Public research university with an international reputation for excellence in teaching and research

Details last updated 03-Nov-2019

Jesús Gil is also referenced in the following:

BSRA Annual Scientific Meeting 2023

06-Sep-2023 to 08-Sep-2023

A compelling lineup of speakers from all areas of the biology of ageing

Jesús Gil News

Telomerase gene therapy prevents age-related lung fibrosis in mice

Pulmonary Fibrosis News - 19-Aug-2020

Could pave way for preventing the disease in humans and improve healthspan

Read more...

Cardiac glycosides may play a role as broad spectrum senolytics

Medical Research Council London Institute of Medical Sciences - 21-Oct-2019

Is it really possible to develop a drug without side effects?

Read more...